Mainz Biomed B.V. – NASDAQ:MYNZ
Mainz Biomed B.V. stock price today
$1.786
-2.81
-61.17%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 2 hours
Mainz Biomed B.V. stock price monthly change
+862.75%
month
Mainz Biomed B.V. stock price quarterly change
+862.75%
quarter
Mainz Biomed B.V. stock price yearly change
+289.83%
year
Mainz Biomed B.V. key metrics
Market Cap | 11.37M |
Enterprise value | 18.81M |
P/E | -3.45 |
EV/Sales | 32.58 |
EV/EBITDA | -1.66 |
Price/Sales | 73.31 |
Price/Book | 1.78 |
PEG ratio | N/A |
EPS | -1.63 |
Revenue | 895.47K |
EBITDA | -24.82M |
Income | -26.36M |
Revenue Q/Q | 11.11% |
Revenue Y/Y | 68.99% |
Profit margin | -2024.79% |
Oper. margin | -1624.54% |
Gross margin | 30.77% |
EBIT margin | -1624.54% |
EBITDA margin | -2772.75% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeMainz Biomed B.V. stock price history
Mainz Biomed B.V. stock forecast
Mainz Biomed B.V. financial statements
| Mar 2023 | 250.10K | -6.63M | -2652.61% |
|---|---|---|---|
| Jun 2023 | 248.94K | -8.25M | -3314.68% |
| Sep 2023 | 181.66K | -6.29M | -3467.71% |
| Dec 2023 | 214.76K | -5.18M | -2413.53% |
| Sep 2023 | 181.66K | -6.29M | -3467.71% |
|---|---|---|---|
| Dec 2023 | 214.76K | -5.18M | -2413.53% |
| Sep 2025 | 1.6M | -2.53M | -158.74% |
| Dec 2025 | 2.1M | -2.32M | -110.87% |
Analysts Price target
Financials & Ratios estimates
| 2024-12-12 | -4.4 | -4.4 |
|---|
| Mar 2023 | 19537707 | 9.86M | 50.47% |
|---|---|---|---|
| Jun 2023 | 19305106 | 14.12M | 73.18% |
| Sep 2023 | 17906795 | 14.45M | 80.74% |
| Dec 2023 | 15409028 | 12.15M | 78.91% |
| Mar 2023 | -5.65M | -1.40M | 773.48K |
|---|---|---|---|
| Jun 2023 | -5.11M | -123.62K | 5.41M |
| Sep 2023 | -6.50M | -112.47K | 4.56M |
| Dec 2023 | -4.65M | -261.80K | 3.46M |
Mainz Biomed B.V. alternative data
| Aug 2023 | 58 |
|---|---|
| Sep 2023 | 58 |
| Oct 2023 | 58 |
| Nov 2023 | 58 |
| Dec 2023 | 58 |
| Jan 2024 | 58 |
| Feb 2024 | 58 |
| Mar 2024 | 58 |
| Apr 2024 | 58 |
| May 2024 | 65 |
| Jun 2024 | 65 |
| Jul 2024 | 65 |
Mainz Biomed B.V. other data
0.03%
-0.11%
of MYNZ is owned by hedge funds
4.37K
-15.72K
shares is hold by hedge funds
-
What's the price of Mainz Biomed B.V. stock today?
One share of Mainz Biomed B.V. stock can currently be purchased for approximately $1.79.
-
When is Mainz Biomed B.V.'s next earnings date?
Unfortunately, Mainz Biomed B.V.'s (MYNZ) next earnings date is currently unknown.
-
Does Mainz Biomed B.V. pay dividends?
No, Mainz Biomed B.V. does not pay dividends.
-
How much money does Mainz Biomed B.V. make?
Mainz Biomed B.V. has a market capitalization of 11.37M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 69% to 895.48K US dollars. Mainz Biomed B.V. made a loss 26.3M US dollars in net income (profit) last year or -$4.4 on an earnings per share basis.
-
What is Mainz Biomed B.V.'s stock symbol?
Mainz Biomed B.V. is traded on the NASDAQ under the ticker symbol "MYNZ".
-
What is Mainz Biomed B.V.'s primary industry?
Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
-
How do i buy shares of Mainz Biomed B.V.?
Shares of Mainz Biomed B.V. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Mainz Biomed B.V. have?
As Jul 2024, Mainz Biomed B.V. employs 65 workers, which is 12% more then previous quarter.
-
When Mainz Biomed B.V. went public?
Mainz Biomed B.V. is publicly traded company for more then 3 years since IPO on 5 Nov 2021.
-
What is Mainz Biomed B.V.'s official website?
The official website for Mainz Biomed B.V. is mainzbiomed.com.
-
How can i contact Mainz Biomed B.V.?
Mainz Biomed B.V. can be reached via phone at +49 6131 5542860.
Mainz Biomed B.V. company profile:
Mainz Biomed B.V.
mainzbiomed.comExchange:
NASDAQ
Full time employees:
65
Industry:
Medical - Diagnostics & Research
Sector:
Healthcare
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.
Robert Koch Strasse 50
Mainz, 55129
Mainz, 55129
CIK: 0001874252
ISIN: NL0015000LC2
CUSIP: N5436L101
